Logo image of NICU.CA

MAGNA MINING INC (NICU.CA) Stock Fundamental Analysis

TSX-V:NICU - TSX Venture Exchange - CA55925F1027 - Common Stock - Currency: CAD

1.8  +0.04 (+2.27%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NICU. NICU was compared to 808 industry peers in the Metals & Mining industry. The financial health of NICU is average, but there are quite some concerns on its profitability. NICU has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NICU had negative earnings in the past year.
NICU had a negative operating cash flow in the past year.
In the past 5 years NICU always reported negative net income.
In the past 5 years NICU always reported negative operating cash flow.
NICU.CA Yearly Net Income VS EBIT VS OCF VS FCFNICU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of NICU (-41.11%) is worse than 61.51% of its industry peers.
NICU has a Return On Equity (-46.42%) which is in line with its industry peers.
Industry RankSector Rank
ROA -41.11%
ROE -46.42%
ROIC N/A
ROA(3y)-53.61%
ROA(5y)N/A
ROE(3y)-65.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NICU.CA Yearly ROA, ROE, ROICNICU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for NICU so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NICU.CA Yearly Profit, Operating, Gross MarginsNICU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, NICU has more shares outstanding
Compared to 5 years ago, NICU has more shares outstanding
NICU has a better debt/assets ratio than last year.
NICU.CA Yearly Shares OutstandingNICU.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NICU.CA Yearly Total Debt VS Total AssetsNICU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

An Altman-Z score of 43.60 indicates that NICU is not in any danger for bankruptcy at the moment.
NICU has a better Altman-Z score (43.60) than 87.13% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that NICU is not too dependend on debt financing.
NICU has a Debt to Equity ratio (0.00) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 43.6
ROIC/WACCN/A
WACCN/A
NICU.CA Yearly LT Debt VS Equity VS FCFNICU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

NICU has a Current Ratio of 5.77. This indicates that NICU is financially healthy and has no problem in meeting its short term obligations.
NICU has a better Current ratio (5.77) than 77.97% of its industry peers.
A Quick Ratio of 5.77 indicates that NICU has no problem at all paying its short term obligations.
With a decent Quick ratio value of 5.77, NICU is doing good in the industry, outperforming 78.22% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.77
Quick Ratio 5.77
NICU.CA Yearly Current Assets VS Current LiabilitesNICU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

3

3. Growth

3.1 Past

NICU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -55.23%.
EPS 1Y (TTM)-55.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.12%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

NICU is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 137.22% yearly.
The Revenue is expected to grow by 179.29% on average over the next years. This is a very strong growth
EPS Next Y195%
EPS Next 2Y123.61%
EPS Next 3Y185%
EPS Next 5Y137.22%
Revenue Next Year683.08%
Revenue Next 2Y386.59%
Revenue Next 3Y266.47%
Revenue Next 5Y179.29%

3.3 Evolution

NICU.CA Yearly Revenue VS EstimatesNICU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 100M 200M 300M
NICU.CA Yearly EPS VS EstimatesNICU.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NICU. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 93.80, the valuation of NICU can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NICU indicates a rather cheap valuation: NICU is cheaper than 85.27% of the companies listed in the same industry.
NICU's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.19.
Industry RankSector Rank
PE N/A
Fwd PE 93.8
NICU.CA Price Earnings VS Forward Price EarningsNICU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NICU.CA Per share dataNICU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1 0.15

4.3 Compensation for Growth

NICU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NICU's earnings are expected to grow with 185.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.61%
EPS Next 3Y185%

More info and screens

0

5. Dividend

5.1 Amount

NICU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAGNA MINING INC

TSX-V:NICU (6/19/2025, 7:00:00 PM)

1.8

+0.04 (+2.27%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-09 2025-04-09
Earnings (Next)N/A N/A
Inst Owners18.15%
Inst Owner ChangeN/A
Ins Owners8.53%
Ins Owner ChangeN/A
Market Cap354.80M
Analysts82.86
Price Target2.79 (55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.46%
PT rev (3m)30.16%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 93.8
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 10.12
P/tB 10.12
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0.02
Fwd EY1.07%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)-0.09
OCFYN/A
SpS0
BVpS0.18
TBVpS0.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.11%
ROE -46.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-53.61%
ROA(5y)N/A
ROE(3y)-65.13%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 29.36%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.77
Quick Ratio 5.77
Altman-Z 43.6
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)86.02%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-55.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-58.12%
EPS Next Y195%
EPS Next 2Y123.61%
EPS Next 3Y185%
EPS Next 5Y137.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year683.08%
Revenue Next 2Y386.59%
Revenue Next 3Y266.47%
Revenue Next 5Y179.29%
EBIT growth 1Y-52.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year148.79%
EBIT Next 3Y113.51%
EBIT Next 5Y86.68%
FCF growth 1Y-67.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.28%
OCF growth 3YN/A
OCF growth 5YN/A